Blood test panel for detecting and characterizing genetic and epigenetic mutations in circulating tumor DNA. Helps determine cancer origin, measure tumor burden, and identify new mutations during targeted therapy treatment.
Manufactured by
Jyvaskyla, Finland
BiopSense is developing a fully automated blood processing solution to help health care professionals, such as laboratories to solve the current complicated biopsy workflows with our unique cartridge technology. With the number of treatment options constantly increasing, more frequent monitoring helps the oncologists to respond more quickly in case the treatment is not satisfactory, or a drug resistance is induced. As a result, the patient will receive efficient treatment faster. Cancer medications are often expensive and predicting the effect could be hard, but they can also have the potential to completely cure the cancer. That is why it is important to find the correct medication right as soon as possible. Therefore, screening and constant monitoring for cancer with liquid biopsy is an effective way to improve the quality of cancer treatments and to reduce the burden of cancer. We aim to replace invasive sampling with a less and non-invasive option – liquid biopsy sampling - fully automated.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Burning Rock Dx Co. Ltd.
China · 5 relevant products
Fujirebio Diagnostics,Inc.
China · 1 relevant product
TRUPCR Europe Ltd
United Kingdom · 5 relevant products
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept
India · 3 relevant products
Genes 2Me Private Ltd
India · 2 relevant products
Bioantibody Biotechnology Co., Ltd.
China · 1 relevant product
YouSeq
United Kingdom · 2 relevant products
Medicover Genetics Ltd
Cyprus · 1 relevant product
Rayto Life and Analytical Sciences Co., Ltd.
China · 1 relevant product
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd
China · 1 relevant product
56 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →3 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 113 closest product alternatives
Burning Rock Dx Co. Ltd. · China
Focused testing panel targeting common cancer-associated mutations for rapid diagnostic confirmation. Provides quick results for urgent treatment decisions.
Burning Rock Dx Co. Ltd. · China
Next-generation sequencing panel for comprehensive cancer genomic profiling. Identifies mutations, copy number variations, and other genetic alterations to guide personalized treatment strategies.
Fujirebio Diagnostics,Inc. · China
In vitro diagnostic test panel for detection of multiple tumor markers with simplified experimental workflow and reliable accuracy. The assay provides stable results suitable for cancer screening and monitoring.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit for detecting mutations associated with lung cancer. This panel identifies genetic alterations relevant to lung cancer diagnosis and treatment planning.
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept · India
Diagnostic kit for detecting relevant mutations in colorectal cancer tissue samples. Identifies mutations affecting prognosis and treatment selection.
Genes 2Me Private Ltd · India
Genomic sequencing panel for cancer-related mutation and biomarker detection. Supports precision oncology treatment planning and selection.
Bioantibody Biotechnology Co., Ltd. · China
Quantitative immunoassay for cancer-related tumor markers. Supports cancer screening, diagnosis, and treatment monitoring.
YouSeq · United Kingdom
A multiplex molecular panel utilizing qPCR and NGS technology for detection of breast cancer-associated genetic markers and mutations. Supports diagnostic confirmation and prognostic assessment for breast cancer management.
Medicover Genetics Ltd · Cyprus
Genetic testing for cancer predisposition and somatic cancer variants to identify individuals at risk or with diagnosed malignancies. Includes comprehensive sequencing with clinical validation and genetic counselling.
TRUPCR Europe Ltd · United Kingdom
A diagnostic test kit designed to detect mutations associated with colorectal cancer. This panel enables identification of genetic alterations relevant to colorectal cancer diagnosis and management.
Rayto Life and Analytical Sciences Co., Ltd. · China
Multi-analyte immunoassay for cancer screening and monitoring biomarkers. Supports oncology patient management and follow-up.
YouSeq · United Kingdom
An NGS-based panel for detection of inherited genetic mutations associated with hereditary cancer syndromes. Enables identification of cancer predisposition for risk stratification and preventive clinical decision-making.
101 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products